Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-16-142414
Filing Date
2016-09-22
Accepted
2016-09-22 14:14:33
Documents
1
Period of Report
2016-09-20

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 3940
  Complete submission text file 0001209191-16-142414.txt   6163
Mailing Address 1616 EASTLAKE AVE. E SUITE 310 SEATTLE WA 98102
Business Address 1616 EASTLAKE AVE. E SUITE 310 SEATTLE WA 98102 (206) 682-0645
Immune Design Corp. (Issuer) CIK: 0001437786 (see all company filings)

EIN.: 262007174 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1700 OWENS STREET SUITE 500 SAN FRANCISCO CA 94158
Business Address 1700 OWENS STREET SUITE 500 SAN FRANCISCO CA 94158 4158652050
COLUMN GROUP II, LP (Reporting) CIK: 0001600420 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-36561 | Film No.: 161897403

Mailing Address 1700 OWENS STREET, SUITE 500 SAN FRANCISCO CA 94158
Business Address 1700 OWENS STREET, SUITE 500 SAN FRANCISCO CA 94158 415-865-2050
Column Group II GP, LP (Reporting) CIK: 0001645333 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-36561 | Film No.: 161897402